Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
2026-10-15 21:54
•Sara Appino •The Motley Fool
••• •• Axe Cap view
Tilray Edges Out Canopy Growth in Cannabis Race for 2026
Tilray’s scale and diversification give it the edge over Canopy Growth, despite risks in both names.
The cannabis sector remains turbulent, and while Canadian giants Canopy Growth and Tilray Brands chart different courses, Tilray’s recent results suggest it’s better equipped to navigate the road ahead. Canopy’s premium focus and European medical push are promising but overshadowed by weak internal controls and ongoing cash losses. Meanwhile, Tilray’s diversification—especially its move into cannabis beverages with BrewDog—supports more robust revenue growth and improving margins. For South African investors, this is less about getting direct exposure to local markets and more about gauging risk appetite through the USD/ZAR lens; a stronger dollar often pressures high-growth global sectors, including cannabis. Tilray’s scale and clearer path to profitability justify a cautious tilt in its favor, but both names remain volatile. If regulatory headwinds lighten or Canopy solves its internal issues faster than expected, this view could flip. this is just our opinion and not financial advice
We would watch Tilray closely and consider a small, risk-aware position given its better growth and diversification, while avoiding Canopy until it shows stronger operational controls and steadier cash flow.
- TLRY
- CGC
- USD/ZAR
- Regulatory delays impacting US and European markets
- Volatile USD/ZAR exchange affecting funding and returns
5/10
The article compares two major cannabis companies navigating industry challenges. Canopy Growth focuses on premium Canadian cannabis and European medical sales but faces internal control weaknesses and significant losses. Tilray Brands has diversified into beverages and international markets, posting record Q1 revenue of $257M with improving margins. The author recommends Tilray as the better choice due to its larger scale, diversified revenue streams, and clearer path to profitability, though both stocks remain risky investments in a volatile industry.
Our take is based on reporting first published by The Motley Fool.